Search

everythinglearnresearchcommunity

for

Search:↓

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

LLLT helps treat hair loss by increasing blood flow, reducing inflammation, and stimulating growth factors.

Hair growth genes work better with more glucose due to changes in gene-regulating markers.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Hair loss in Rhesus macaques may be caused by a skin allergy-related condition.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

High TSPEAR levels in colorectal cancer predict worse outcomes.

High TSPEAR levels in colorectal cancer predict worse outcomes.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

A girl with severe hair loss saw hair regrowth after using cannabis.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

Antibiotics often cause skin reactions, making them a major health concern.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Stem-cell therapy shows promise for skin conditions but needs more research.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

Cannabinoids might help treat skin problems but more research is needed to be sure.

New understanding and treatments for hair loss are improving, but more research is needed.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.